- Home
- CIA vs CDXS Comparison
CIA vs CDXS Comparison
Compare CIA & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIA | CDXS |
|---|---|---|
| Founded | 1969 | 2002 |
| Country | United States | United States |
| Employees | 246 | N/A |
| Industry | Life Insurance | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 256.3M |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CIA | CDXS |
|---|---|---|
| Price | $5.54 | $2.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 80.4K | ★ 756.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $255,616,000.00 | $138,590,000.00 |
| Revenue This Year | $3.10 | $7.73 |
| Revenue Next Year | $4.47 | $14.24 |
| P/E Ratio | $28.23 | ★ N/A |
| Revenue Growth | 4.33 | ★ 32.30 |
| 52 Week Low | $3.25 | $0.96 |
| 52 Week High | $6.40 | $3.87 |
Technical Indicators
Market Signals| Indicator | CIA | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 44.97 |
| Support Level | $5.14 | $2.39 |
| Resistance Level | $5.63 | $2.56 |
| Average True Range (ATR) | 0.33 | 0.15 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 84.81 | 16.52 |
Price Performance
Historical ComparisonAbout CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Domestic Insurance and International Insurance segments.. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.